What is LOPJLB’s current signal on CTMX?

LOPJLB’s latest quantitative signal on CytomX Therapeutics, Inc. (CTMX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CTMX in?

CytomX Therapeutics, Inc. (CTMX) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is CytomX Therapeutics, Inc. based / listed?

CytomX Therapeutics, Inc. is based in US, listed on NASDAQ.

CytomX Therapeutics, Inc. (CTMX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.47-3.14%Close

SELLCRISIS · day 20

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $397M
Beta: 2.20
P/E (TTM): -5.69

Short % float: 27.62%
Days to cover: 9.3
SI change: +15.3%

1W: -6.08%
1M: -30.23%

vs SPY 1W: -7.64%
vs SPY 1M: -31.99%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

CytomX Therapeutics, Inc. is a United States-based biopharmaceutical company primarily focused on creating treatments for cancer. The company utilizes its proprietary Probody technology platform to engineer targeted antibody therapeutics for oncological applications. Its robust…

Employees: 69
Headquarters: US
Founded: 2015
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 160.8M
Float: 87.0%

cytomx.com ↗

Key executives

Sean A. McCarthy DPHIL — Chairman & Chief Executive Officer

Christopher W. Ogden — SVP, CFO & Secretary

Marcia Belvin — Senior Vice President & Chief Scientific Officer

SEC filings

EDGAR · CIK 15019890 · CTMX

Analyst consensus

Buy

Bullish1781.0%

Neutral419.0%

Bearish00.0%

L $6.00Avg $8.50H $11.00

Target$8.50+244.13%

Last$2.47

Key stats

Industry peers

Prediction markets

Company news